The Effects of CYP2D6*10 Polymorphisms on Tamoxifen Metabolism, Bone Mineral Density and Clinical Outcomes in Taiwanese Breast Cancer Patients and In vitro study of Tamoxifen and its Active Metabolites on Osteoclast.
碩士 === 國防醫學院 === 藥學研究所 === 101 === Tamoxifen is the drug of choice as an adjuvant hormonal therapy for premenopausal estrogen and/or progesterone receptor positive breast cancer patients, yet it also plays an important role in managing postmenopausal hormonal receptor positive breast cancer pati...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2013
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/43382062360311624174 |